title: [Analysis of immune response to tumor specific antigen restricted to HLA class II on renal cell carcinoma and its recognition mechanism].
abstract: OBJECTIVE
  In this study, we studied the immune response against to human renal cell carcinoma and its antigensity.
  
  
  METHODS
  Mixed lymphocyte tumor culture test was performed using tumor cells as stimulator cells, peripheral blood lymphocytes from tumor patient (autologous) or healthy volunteer (allogeneic) as responder cells, and tumor cells or peripheral blood lymphocytes from tumor patient as target cells. The cytotoxic activity of mixed lymphocyte tumor culture test was assayed by 51Cr-relase test, and cell surface antigens presented on tumor cells or peripheral blood lymphocytes were assayed by antibody block test.
  
  
  RESULTS
  The cytotoxic activity against to tumor cells was induced from allogeneic peripheral blood lymphocytes by mixed lymphocyte tumor culture test. Its cytotoxic activity was inhibited by anti-CD8 antibody treatment of peripheral blood lymphocytes and anti-HLA class II antibody treatment of tumor cells. Furthermore, allogeneic peripheral blood lymphocytes induced to tumor cells did not damage peripheral blood lymphocyte of the tumor patient derivation.
  
  
  CONCLUSIONS
  Renal cell carcinoma may express tumor specific antigen restricted to HLA class II antigens that could be recognized by allogeneic CD8 positive T lymphocytes.
authors.affiliation: Department of Urology, Faculty of Medicine, University of the Ryukyus.
authors.forename: Saori
authors.initials: S
authors.lastname: Nishijima
authors.forename: Kimio
authors.initials: K
authors.lastname: Sugaya
authors.forename: Yoshihide
authors.initials: Y
authors.lastname: Ogawa
authors.forename: Hideki
authors.initials: H
authors.lastname: Mukouyama
authors.forename: Katsumasa
authors.initials: K
authors.lastname: Shimada
mesh_terms: D016827:CD8 Antigens / Q000276:immunology; D002292:Carcinoma, Renal Cell / Q000276:immunology* / Q000473:pathology; D003601:Cytotoxicity Tests, Immunologic; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology* / Q000473:pathology; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008875:Middle Aged; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D016827:CD8 Antigens; D000949:Histocompatibility Antigens Class II